215 related articles for article (PubMed ID: 16455073)
1. Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease.
Abraham WM; Scuri M; Farmer SG
Eur J Pharmacol; 2006 Mar; 533(1-3):215-21. PubMed ID: 16455073
[TBL] [Abstract][Full Text] [Related]
2. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
[TBL] [Abstract][Full Text] [Related]
3. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.
Leeb-Lundberg LM; Marceau F; Müller-Esterl W; Pettibone DJ; Zuraw BL
Pharmacol Rev; 2005 Mar; 57(1):27-77. PubMed ID: 15734727
[TBL] [Abstract][Full Text] [Related]
4. MEN16132, a kinin B2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways.
Valenti C; Cialdai C; Giuliani S; Tramontana M; Quartara L; Maggi CA
Eur J Pharmacol; 2008 Jan; 579(1-3):350-6. PubMed ID: 18036587
[TBL] [Abstract][Full Text] [Related]
5. Knee osteoarthritis: a role for bradykinin?
Meini S; Maggi CA
Inflamm Res; 2008 Aug; 57(8):351-61. PubMed ID: 18787773
[TBL] [Abstract][Full Text] [Related]
6. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
8. The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammation.
Pietrovski EF; Otuki MF; Regoli D; Bader M; Pesquero JB; Cabrini DA; Zampronio AR
Regul Pept; 2009 Jan; 152(1-3):67-72. PubMed ID: 18977249
[TBL] [Abstract][Full Text] [Related]
9. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
Morissette G; Bouthillier J; Marceau F
Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin receptor antagonists--a review of the patent literature 2005-2008.
Fincham CI; Bressan A; Paris M; Rossi C; Fattori D
Expert Opin Ther Pat; 2009 Jul; 19(7):919-41. PubMed ID: 19552510
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
12. Vascular B1 kinin receptors in patients with congestive heart failure.
Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
[TBL] [Abstract][Full Text] [Related]
13. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
Charignon D; Späth P; Martin L; Drouet C
Expert Opin Pharmacother; 2012 Oct; 13(15):2233-47. PubMed ID: 22970904
[TBL] [Abstract][Full Text] [Related]
14. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.
Del Corso I; Puxeddu I; Sardano E; Geraci S; Breggia M; Rocchi V; Migliorini P
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):460-1. PubMed ID: 22626601
[No Abstract] [Full Text] [Related]
15. Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats.
Cialdai C; Giuliani S; Valenti C; Tramontana M; Maggi CA
J Pharmacol Exp Ther; 2009 Dec; 331(3):1025-32. PubMed ID: 19745108
[TBL] [Abstract][Full Text] [Related]
16. Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats.
Werner MF; Kassuya CA; Ferreira J; Zampronio AR; Calixto JB; Rae GA
Neuropharmacology; 2007 Jul; 53(1):48-57. PubMed ID: 17555775
[TBL] [Abstract][Full Text] [Related]
17. Modulation of allergic and immune complex-induced lung inflammation by bradykinin receptor antagonists.
Gama Landgraf R; Jancar S; Steil AA; Sirois P
Inflamm Res; 2004 Feb; 53(2):78-83. PubMed ID: 15021973
[TBL] [Abstract][Full Text] [Related]
18. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
Bas M; Bier H; Greve J; Kojda G; Hoffmann TK
Allergy; 2006 Dec; 61(12):1490-2. PubMed ID: 17073887
[No Abstract] [Full Text] [Related]
19. Bradykinin B2 receptor antagonism: a new direction for acute stroke therapy?
Sobey CG
Br J Pharmacol; 2003 Aug; 139(8):1369-71. PubMed ID: 12922922
[TBL] [Abstract][Full Text] [Related]
20. [Bradykinin antagonist: current status and perspective].
Hirayama Y; Kayakiri H
Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):45-53. PubMed ID: 11862756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
